BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4277409)

  • 1. Coagulolysis: mechanism of formation and lysis of dilute whole blood clots and application of this assay into study of certain hypercoagulable states.
    Taylor FB; Nilsson UR; Creech RH; Carroll ET; Beisswenger JG
    Ser Haematol; 1973; 6(4):528-48. PubMed ID: 4277409
    [No Abstract]   [Full Text] [Related]  

  • 2. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
    Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
    Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of bile salts on some coagulation components and related enzymes.
    Engel AM; Alexander B
    Thromb Diath Haemorrh; 1972 Jul; 27(3):594-609. PubMed ID: 4268053
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.
    Egberg N
    Acta Physiol Scand Suppl; 1973; 400():1-47. PubMed ID: 4599946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Platelet function in relation to blood coagulation and fibrinolysis].
    Koike K
    Rinsho Ketsueki; 1975 Apr; 16(4):408-14. PubMed ID: 124789
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemostatic defects in polycythaemia vera.
    Stathakis NE; Papayannis AG; Arapakis G; Gardikas C
    Blut; 1974 Aug; 29(2):77-86. PubMed ID: 4852216
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulation, oestrogen and the menopause.
    Notelovitz M
    Clin Obstet Gynaecol; 1977 Apr; 4(1):107-28. PubMed ID: 140032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation studies of menopausal women taking estrogen replacement.
    Beller FK; Nachtigall L; Rosenberg M
    Obstet Gynecol; 1972 May; 39(5):775-8. PubMed ID: 4260072
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental models of defibrination states.
    Lipiński B
    Pol Med J; 1971; 10(3):619-26. PubMed ID: 4256509
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study.
    Gormsen J; Tidstrom B; Feddersen C; Ploug J
    Acta Med Scand; 1973; 194(3):191-8. PubMed ID: 4583532
    [No Abstract]   [Full Text] [Related]  

  • 12. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 17. The biology of thrombosis.
    Nemerson Y; Nossel HL
    Annu Rev Med; 1982; 33():479-88. PubMed ID: 6211132
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutual interaction between platelets and fibrinogen and its derivatives.
    Stachurska J; Wegrzynowicz Z; Latallo ZS; Kopec M
    Acta Univ Carol Med Monogr; 1972; 53():17-20. PubMed ID: 4275439
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity.
    Medhat IA; Toppozada HK; Rizk MA; Khowessah MM; Malek AT; Moghazi M
    Contraception; 1974 Apr; 9(4):379-92. PubMed ID: 4442281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.